439 related articles for article (PubMed ID: 31622652)
1. Hybrid nanocrystal-amorphous solid dispersions (HyNASDs) as alternative to ASDs for enhanced release of BCS Class II drugs.
Rahman M; Arevalo F; Coelho A; Bilgili E
Eur J Pharm Biopharm; 2019 Dec; 145():12-26. PubMed ID: 31622652
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Characterization of Spray-Dried Hybrid Nanocrystal-Amorphous Solid Dispersions (HyNASDs) for Supersaturation Enhancement of a Slowly Crystallizing Drug.
Rahman M; Radgman K; Tarabokija J; Ahmad S; Bilgili E
Nanomaterials (Basel); 2023 Aug; 13(17):. PubMed ID: 37686927
[TBL] [Abstract][Full Text] [Related]
3. Synergistic and antagonistic effects of various amphiphilic polymer combinations in enhancing griseofulvin release from ternary amorphous solid dispersions.
Rahman M; Coelho A; Tarabokija J; Ahmad S; Radgman K; Bilgili E
Eur J Pharm Sci; 2020 Jul; 150():105354. PubMed ID: 32380151
[TBL] [Abstract][Full Text] [Related]
4. Spray-Dried Amorphous Solid Dispersions of Griseofulvin in HPC/Soluplus/SDS: Elucidating the Multifaceted Impact of SDS as a Minor Component.
Rahman M; Ahmad S; Tarabokija J; Parker N; Bilgili E
Pharmaceutics; 2020 Feb; 12(3):. PubMed ID: 32106495
[TBL] [Abstract][Full Text] [Related]
5. Enhanced recovery and dissolution of griseofulvin nanoparticles from surfactant-free nanocomposite microparticles incorporating wet-milled swellable dispersants.
Bhakay A; Azad M; Vizzotti E; Dave RN; Bilgili E
Drug Dev Ind Pharm; 2014 Nov; 40(11):1509-22. PubMed ID: 23981202
[TBL] [Abstract][Full Text] [Related]
6. Spray drying of drug-swellable dispersant suspensions for preparation of fast-dissolving, high drug-loaded, surfactant-free nanocomposites.
Azad M; Arteaga C; Abdelmalek B; Davé R; Bilgili E
Drug Dev Ind Pharm; 2015; 41(10):1617-31. PubMed ID: 25347144
[TBL] [Abstract][Full Text] [Related]
7. A comparative assessment of nanocomposites vs. amorphous solid dispersions prepared via nanoextrusion for drug dissolution enhancement.
Li M; Ioannidis N; Gogos C; Bilgili E
Eur J Pharm Biopharm; 2017 Oct; 119():68-80. PubMed ID: 28583589
[TBL] [Abstract][Full Text] [Related]
8. Redispersible fast dissolving nanocomposite microparticles of poorly water-soluble drugs.
Bhakay A; Azad M; Bilgili E; Dave R
Int J Pharm; 2014 Jan; 461(1-2):367-79. PubMed ID: 24333905
[TBL] [Abstract][Full Text] [Related]
9. Effect of Particle Size and Polymer Loading on Dissolution Behavior of Amorphous Griseofulvin Powder.
Zheng K; Lin Z; Capece M; Kunnath K; Chen L; Davé RN
J Pharm Sci; 2019 Jan; 108(1):234-242. PubMed ID: 30472263
[TBL] [Abstract][Full Text] [Related]
10. Investigation of novel supersaturating drug delivery systems of chlorthalidone: The use of polymer-surfactant complex as an effective carrier in solid dispersions.
França MT; Nicolay Pereira R; Klüppel Riekes M; Munari Oliveira Pinto J; Stulzer HK
Eur J Pharm Sci; 2018 Jan; 111():142-152. PubMed ID: 28964949
[TBL] [Abstract][Full Text] [Related]
11. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
12. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
13. Atypical effects of incorporated surfactants on stability and dissolution properties of amorphous polymeric dispersions.
Al-Obaidi H; Lawrence MJ; Buckton G
J Pharm Pharmacol; 2016 Nov; 68(11):1373-1383. PubMed ID: 27696396
[TBL] [Abstract][Full Text] [Related]
14. Quiescent and Agitated Redispersion as a Tool for Evaluating Dispersant Effectiveness in Dissolution Enhancement of Drug-Laden Nanocomposites.
Bhakay A; Davé RN; Bilgili E
AAPS PharmSciTech; 2018 Jan; 19(1):436-447. PubMed ID: 28770528
[TBL] [Abstract][Full Text] [Related]
15. Impact of Matrix Surface Area on Griseofulvin Release from Extrudates Prepared via Nanoextrusion.
Li M; Furey C; Skros J; Xu O; Rahman M; Azad M; Dave R; Bilgili E
Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371728
[TBL] [Abstract][Full Text] [Related]
16. Multi-faceted Characterization of Wet-milled Griseofulvin Nanosuspensions for Elucidation of Aggregation State and Stabilization Mechanisms.
Li M; Alvarez P; Orbe P; Bilgili E
AAPS PharmSciTech; 2018 May; 19(4):1789-1801. PubMed ID: 29603084
[TBL] [Abstract][Full Text] [Related]
17. Amorphous solid dispersion of nisoldipine by solvent evaporation technique: preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study.
Chavan RB; Lodagekar A; Yadav B; Shastri NR
Drug Deliv Transl Res; 2020 Aug; 10(4):903-918. PubMed ID: 32378174
[TBL] [Abstract][Full Text] [Related]
18. Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect.
Monteiro A; Afolabi A; Bilgili E
Drug Dev Ind Pharm; 2013 Feb; 39(2):266-83. PubMed ID: 22503097
[TBL] [Abstract][Full Text] [Related]
19. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
20. Is the combination of cellulosic polymers and anionic surfactants a good strategy for ensuring physical stability of BCS Class II drug nanosuspensions?
Bilgili E; Li M; Afolabi A
Pharm Dev Technol; 2016; 21(4):499-510. PubMed ID: 25774989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
